logo

For the Inventor, By the Inventor

Zagreb, Croatia

Zeljko Kelneri C

This inventor holds 1 USPTO granted patent. Top assignee: Pliva Farmaceutiska, Kemijska, Prehrambena I Kozmeticka Industrija,. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zeljko Kelneri C. Retrieved from https://idiyas.com/inventor/zeljko-kelneri-c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 1 
 
Pliva Farmaceutiska, Kemijska, Prehrambena I Kozmeticka Industrija,
 patent

Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents
1. 5629296 - 9A-N-(N'-carbamoyl)and 9A-N-(N'-thiocarbamoyl) derivatives of (1997-05-13),

Title: Zeljko Kelneri C: Innovator in Macrolide Antibiotics

Introduction

Zeljko Kelneri C is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. His work focuses on semisynthetic macrolide antibiotics, which are crucial in treating bacterial infections.

Latest Patents

Zeljko holds a patent for the invention titled "9A-N-(N'-carbamoyl) and 9A-N-(N'-thiocarbamoyl) derivatives." This invention relates to 9a-N-(N'-carbamoyl) and 9a-N-(N'-thiocarbamoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin A. These derivatives are part of the azalide series and are represented by a specific chemical formula. The invention also covers the preparation processes for these compounds and their use in pharmaceutical compositions for treating bacterial infections.

Career Highlights

Zeljko is associated with Pliva Farmaceutiska, Kemijska, Prehrambena I Kozmeticka Industrija, a prominent company in the pharmaceutical industry. His work at Pliva has allowed him to focus on innovative solutions in antibiotic development.

Collaborations

Zeljko has collaborated with several professionals in his field, including Nedjeliko Kujund Zi C and Gabrijela Kobrehel. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Zeljko Kelneri C is a distinguished inventor whose work in macrolide antibiotics has the potential to impact the treatment of bacterial infections significantly. His innovative approach and collaboration with other professionals highlight the importance of teamwork in scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…